ACRS Q4 2017 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

Q4 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$999,000

Gross Profit

$245,00024.5% margin

Operating Income

-$25M-2546.7% margin

Net Income

-$23M-2295.7% margin

EPS (Diluted)

$-0.74

QoQ Revenue Growth

+46.1%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$244M

Total Liabilities

$18M

Stockholders' Equity

$225M

Cash & Equivalents

$209M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$999,000	$0	—
Gross Profit	$245,000	$0	—
Operating Income	-$25M	-$12M	-118.8%
Net Income	-$23M	-$11M	-99.9%